Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Liver Failure/Cirrhosis/Portal Hypertension"'
Autor:
Paolo Caraceni, Anna Baldan, Pierluigi Viale, Katja Waterstradt, Paola Paterini, Marina Naldi, Marco Domenicali, Martina Gagliardi, Michele Bartoletti, Mauro Bernardi, Simona Leoni, Manuel Tufoni, Giacomo Zaccherini, Maurizio Baldassarre, Manuela Bartolini, Agnese Antognoli, Franco Trevisani, Maristella Laggetta
Publikováno v:
Hepatology (Baltimore, Md.)
Background and Aims: Circulating albumin in cirrhosis can be dysfunctional because of accumulating structural damages, leading to the concept of effective albumin concentration (eAlb), referring to the albumin portion presenting structural and functi
Autor:
Yudai Fujiwara, Keisuke Kakisaka, Tomoaki Nagasawa, Yasuhiro Takikawa, Tamami Abe, Hidekatsu Kuroda, Yuji Suzuki
Publikováno v:
Hepatology (Baltimore, Md.)
Background and Aims Acute liver failure (ALF) is a rare but dramatic clinical syndrome characterized by massive hepatic necrosis leading to multiorgan failure. It is difficult to predict the outcomes in patients with ALF using existing prognostic mod
Autor:
David Pereyra, Patrick Starlinger, Christoph Köditz, Michael Trauner, G. Ortmayr, Georg Györi, Benedikt Rumpf, Hubert Hackl, Gabriela A. Berlakovich, Thomas Reiberger
Publikováno v:
Hepatology (Baltimore, Md.)
BACKGROUND AND AIMS The Model for End-Stage Liver Disease (MELD) is used for clinical decision-making and organ allocation for orthotopic liver transplantation (OLT) and was previously upgraded through inclusion of serum sodium (Na) concentrations (M
Autor:
B. van Hoek, J. Pirenne, Ian P.J. Alwayn, Serge Vogelaar, Maarten E. Tushuizen, Hein Putter, Ben F J Goudsmit, Andries E. Braat
Publikováno v:
Hepatology. WILEY
Hepatology
Hepatology (Baltimore, Md.)
Hepatology
Hepatology (Baltimore, Md.)
BACKGROUND AND AIMS: The United Network for Organ Sharing's Model for End-Stage Liver Disease (UNOS-MELD) score is the basis of liver allocation in the Eurotransplant region. It was constructed 20 years ago in a small US cohort and has remained uncha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b6cd870b8ac92db2547341800d58576
http://hdl.handle.net/1887/3196202
http://hdl.handle.net/1887/3196202
Autor:
Toshimitsu Ochiai, Markus Peck-Radosavljevic, Tomoko Motomiya, Mihaly Makara, Marius Braun, Sheng-Shun Yang, Nezam H. Afdhal, Zeid Kayali, Ziv Ben Ari, Ajay Duggal, Tsutae Nagata, Paul Mitrut, Meral Akdogan, A. Iacobellis, Albert Tran, Krzysztof Simon, Takeshi Kano, Tarek Hassanein, Mario Pirisi
Publikováno v:
Hepatology (Baltimore, Md.)
Thrombocytopenia may be associated with increased bleeding risk impacting timing and outcome of invasive procedures in patients with chronic liver disease (CLD). Lusutrombopag, a small-molecule, thrombopoietin (TPO) receptor agonist, was evaluated as
Autor:
Laurelle van Tilburg, Robert A. de Man, Nicole S. Erler, Henk R. van Buuren, Manon C.W. Spaander, Rosalie C. Oey, Herold J. Metselaar
Publikováno v:
Hepatology (Baltimore, Md.)
Hepatology, 69(6), 2598-2607. John Wiley & Sons Ltd.
Hepatology, 69(6), 2598-2607. John Wiley & Sons Ltd.
Colorectal cancer (CRC) screening with colonoscopy is commonly used in patients who are candidates for liver transplantation. We initiated this study to define the risk-benefit ratio of performing screening colonoscopy in this population. A retrospec
Autor:
Hoi‐Fan Li, Calvin Ka‐Lam Leung, Tan To Cheung, James Fung, Sui-Ling Sin, Ka Wing Ma, Herbert Pang, Chung Mau Lo, Brian Wong Hoi She, Tiffany C.L. Wong, Albert C. Y. Chan, Jeff W.C. Dai
Publikováno v:
Hepatology (Baltimore, Md.)
Background and Aims Previous recommendations suggested living donor liver transplantation (LDLT) should not be considered for patients with Model for End‐Stage Liver Disease (MELD) > 25 and hepatorenal syndrome (HRS). Approach and Results Patients
Autor:
William Bernal, Sarah Azarian, Javier Fernández, Andrea Calvo, Ton Lisman, Maria Hernandez Tejero, Jelle Adelmeijer, Annabel Blasi, Vishal C. Patel
Publikováno v:
Blasi, A, Patel, V C, Adelmeijer, J, Azarian, S, Tejero, M H, Calvo, A, Fernandez, J, Bernal, W & Lisman, T 2019, ' Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival ', Hepatology . https://doi.org/10.1002/hep.30915
Hepatology, 71(4), 1381-1390. Wiley
Hepatology (Baltimore, Md.)
Hepatology, 71(4), 1381-1390. Wiley
Hepatology (Baltimore, Md.)
Background and AimsPatients with liver disease acquire complex changes in their hemostatic system, which results in a fragile rebalanced status. The status of the fibrinolytic system is controversial, as is the role of fibrinolytic dysfunction in ble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0021f47ffa363c57b910c0b8855e0a
https://kclpure.kcl.ac.uk/en/publications/2a2a8fc3-9dbd-48c6-aa3b-9c957a3982ae
https://kclpure.kcl.ac.uk/en/publications/2a2a8fc3-9dbd-48c6-aa3b-9c957a3982ae
Autor:
Yue Sun, Jiao Guo, Lihang Zhuang, Changzheng Li, Hui Li, Tian Lan, Genshu Wang, Yitao Ou, Guizhi Yang, David A. Brenner, Tatiana Kisseleva
Publikováno v:
Hepatology (Baltimore, Md.)
Hepatology (Baltimore, Md.), vol 68, iss 3
Hepatology (Baltimore, Md.), vol 68, iss 3
Chronic liver disease mediated by activation of hepatic stellate cells (HSCs) and Kupffer cells (KCs) leads to liver fibrosis. Here, we aimed to investigate the molecular mechanism and define the cell type involved in mediating the sphingosine kinase
Autor:
Karin Kozbial, Peter Ferenci, Mattias Mandorfer, Matthias Pinter, Petra Steindl-Munda, Virginia Hernández-Gea, Markus Peck-Radosavljevic, Albert Friedrich Stättermayer, Philipp Schwabl, David Chromy, Monika Fritzer-Szekeres, Thomas Reiberger, Michael Trauner, Juan Carlos García-Pagán, Georg Semmler
Publikováno v:
Hepatology (Baltimore, Md.)
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
BaCKgRoUND aND aIMS: Sustained virologic response (SVR) to interferon (IFN)-free therapies ameliorates portal hypertension (PH); however, it remains unclear whether a decrease in hepatic venous pressure gradient (HVPG) after cure of hepatitis C trans